Eisai
4523.T
#2180
Rank
$8.50 B
Marketcap
$30.15
Share price
0.11%
Change (1 day)
3.07%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: $0.52 Billion USD

According to Eisai's latest financial reports the company's current earnings are $5.06 Billion USD. In 2023 the company made an earning of $0.52 Billion USD, an increase over its 2022 earnings that were of -$22.76 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023$0.52 B-2404.04%
2022-$22.76 Million-103.6%
2021$0.63 B-39.81%
2020$1.05 B7.44%
2019$0.97 B17.22%
2018$0.83 B86.16%
2017$0.44 B-23.52%
2016$0.58 B26.97%
2015$0.46 B22.3%
2014$0.37 B-46.07%
2013$0.70 B-21.85%
2012$0.89 B-20.59%
2011$1.12 B-8.91%
2010$1.23 B19.21%
2009$1.03 B